GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » EV-to-Revenue

Mankind Pharma (BOM:543904) EV-to-Revenue : 11.08 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mankind Pharma's enterprise value is ₹874,852 Mil. Mankind Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹78,937 Mil. Therefore, Mankind Pharma's EV-to-Revenue for today is 11.08.

The historical rank and industry rank for Mankind Pharma's EV-to-Revenue or its related term are showing as below:

BOM:543904' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.2   Med: 7.84   Max: 9.52
Current: 11.08

During the past 3 years, the highest EV-to-Revenue of Mankind Pharma was 9.52. The lowest was 6.20. And the median was 7.84.

BOM:543904's EV-to-Revenue is ranked worse than
88.28% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.38 vs BOM:543904: 11.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-13), Mankind Pharma's stock price is ₹2238.15. Mankind Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹196.86. Therefore, Mankind Pharma's PS Ratio for today is 11.37.


Mankind Pharma EV-to-Revenue Historical Data

The historical data trend for Mankind Pharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma EV-to-Revenue Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22
EV-to-Revenue
- - -

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 9.63 9.47 10.06

Competitive Comparison of Mankind Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mankind Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's EV-to-Revenue falls into.



Mankind Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mankind Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=874852.331/78936.754
=11.08

Mankind Pharma's current Enterprise Value is ₹874,852 Mil.
Mankind Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹78,937 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mankind Pharma  (BOM:543904) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mankind Pharma's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2238.15/196.86
=11.37

Mankind Pharma's share price for today is ₹2238.15.
Mankind Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹196.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mankind Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma (BOM:543904) Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines